BIM
AXSM icon

BlackRock Investment Management’s Axsome Therapeutics AXSM Stock Holding History

BlackRock Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$256K Hold
37,940
– – ﹤0.01% 3197
2016
Q3 		$299K Sell
37,940
-122
-0.3% -$924 ﹤0.01% 3179
2016
Q2 		$287K Buy
38,062
+37,093
+3,828% +$342K ﹤0.01% 3232
2016
Q1 		$8K Buy
+969
New +$8.89K ﹤0.01% 3686

Other funds holding AXSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Investment Management's AXSM Position: Q4 2016 in Review

BlackRock Investment Management held its Axsome Therapeutics (AXSM) position steady in Q4 2016 at 37,940 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #3197.

BlackRock Investment Management first reported a position in AXSM in Q1 2016 and has held it in 4 quarters since. The position peaked at $299K in Q3 2016. 41 funds tracked by Wall St. Rank hold AXSM as of Q4 2016.

  • BlackRock Investment Management held 37,940 shares of Axsome Therapeutics worth $256K as of Q4 2016.
  • BlackRock Investment Management left its Axsome Therapeutics share count unchanged in Q4 2016.
  • Axsome Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3197 holding.
  • BlackRock Investment Management first reported a position in Axsome Therapeutics in Q1 2016 and has held it in 4 quarters since.
  • BlackRock Investment Management's Axsome Therapeutics position peaked at $299K in Q3 2016.
  • 41 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.